MedPath

Comparison of Liraglutide vs. Dulaglutide in type 2 diabetic outpatients using Flash Glucose monitoring (FGM)

Not Applicable
Recruiting
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000030624
Lead Sponsor
Kitasato University School of Pharmacy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with diabetic nephropathy more than stage 4 or with abnormal aspartate aminotransferase/alanine aminotransferase elevation (3 X the upper limit of normal) were excluded from this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath